Magnesium Glycinate Side Effects: What the Evidence Actually Shows
Diarrhea is the main documented side effect and the reason for the 350 mg limit. What two recent reviews found about cramps and sleep, who is genuinely at risk, and which medications interact.
The short answer: the main documented side effect of any oral magnesium supplement is diarrhea, and it is the reason the US upper limit for supplemental magnesium was set at 350 mg per day in 1997 (Costello et al., Adv Nutr, 2023). Glycinate is generally considered gentler on the gut than oxide, but it is not exempt. Serious harm is rare and is concentrated in people with impaired kidney function.
Magnesium glycinate is magnesium bound to the amino acid glycine — one of several salt forms used in supplements, alongside oxide, citrate and L-threonate.
This article is information, not medical advice. Magnesium interacts with several common medications and is genuinely risky in kidney disease. Talk to a doctor or pharmacist before starting it, particularly if you take prescription medicine. See our medical disclaimer.
The key numbers, with sources
- 350 mg/day. The tolerable upper intake level for magnesium from supplements alone for adults, set by the US Institute of Medicine in 1997. Diarrhea was the limiting factor — the UL was not set from organ damage (Costello et al., Adv Nutr, 2023).
- 7 of 10 studies. In a 2023 review of intervention studies published between 1997 and 2022, seven studies using 128–1,200 mg/day of magnesium found no significant difference in diarrhea between supplement and control groups — which is why those authors argue the UL should be re-examined.
- 11 trials, 735 people. The Cochrane review of magnesium for skeletal muscle cramps (Garrison et al., Cochrane Database Syst Rev, 2020).
- RR 1.04 (95% CI 0.84 to 1.29). From that review, the chance of a 25% or better reduction in cramps on magnesium versus placebo in older adults — graded high-certainty evidence. That interval sits squarely across 1.0, meaning no detectable effect.
- 12 randomised trials, certainty low to very low. A 2026 systematic review of magnesium for sleep concluded that current evidence does not support oral magnesium as a routine treatment for insomnia (Lopresti et al., J Diet Suppl, 2026).
What are the actual side effects?
The consistently reported effects are gastrointestinal: loose stools or diarrhea, and sometimes nausea or abdominal cramping. This is a direct consequence of unabsorbed magnesium drawing water into the bowel, which is the same mechanism that makes magnesium salts effective laxatives.
Dose and form both matter. Poorly absorbed forms such as magnesium oxide leave more magnesium in the gut and are more likely to loosen stools. Glycinate’s reputation as gentle is usually explained by better absorption, but the human data for that are thin: in a 1994 trial in 12 people who had part of the small intestine removed, glycinate and oxide were absorbed about equally overall (23.5% vs 22.8%), though glycinate was better tolerated, and in an industry-funded 2024 single-dose crossover study in 40 adults, blood magnesium did not rise significantly after glycinate. Treat its gentleness as plausible rather than proven, and not as a claim that it never causes diarrhea.
| Effect | How often | What the evidence says |
|---|---|---|
| Diarrhea / loose stools | The main one | The limiting factor behind the 350 mg UL. But seven of ten studies at 128–1,200 mg/day found no significant difference versus control (Costello et al., 2023) |
| Nausea, abdominal cramping | Less common | Reported alongside GI upset; usually dose-related and settles on reducing the dose |
| Drowsiness | Anecdotal | Often reported, but the 2026 sleep review found inconsistent effects and low to very low certainty across 12 trials |
| Hypermagnesemia (dangerously high blood magnesium) | Rare, but serious | Concentrated in people with reduced kidney function, who cannot clear excess magnesium. Needs medical supervision, not self-management |
Is the 350 mg limit actually the safety ceiling?
It is widely quoted as one, and that is a misreading. The 350 mg figure is the point above which the 1997 committee judged diarrhea likely — a tolerability threshold, not a toxicity threshold. Magnesium from food is not included in it at all, because dietary magnesium does not carry the same risk in healthy people.
Costello and colleagues searched the 1997–2022 literature and the FDA adverse-event database and reported that most intervention studies, including ones using doses far above 350 mg/day, found no significant excess of diarrhea. They argue the UL should be re-evaluated.
Disclose the conflict: all four authors of that paper are affiliated with the Center for Magnesium Education and Research, an organisation whose purpose is magnesium research and advocacy. That does not make their literature search wrong, but a paper arguing for a higher magnesium limit written by a magnesium research centre is exactly the kind of finding that should be read with the funding source in view. The 350 mg UL remains the official position.
Does magnesium actually help muscle cramps?
For the commonest presentation — idiopathic night-time leg cramps in older adults — the honest answer is no. The Cochrane review pooled 11 trials in 735 people. In participants with idiopathic cramps (mean age 61.6 to 69.3 years), the differences versus placebo were small and not statistically significant.
The numbers: percentage change in cramps per week at four weeks was a mean difference of −9.59% (95% CI −23.14% to 3.97%); absolute cramp frequency differed by −0.18 cramps per week (95% CI −0.84 to 0.49); and the proportion of people getting at least a 25% improvement was no different from placebo (RR 1.04, 95% CI 0.84 to 1.29, high-certainty evidence).
The pregnancy-associated cramp trials pointed in a more favourable direction, but the reviewers judged all five of them at high risk of bias, so they do not carry the same weight. If you are taking magnesium glycinate specifically to stop night cramps, the best available evidence says it is unlikely to work.
Does it help sleep?
Much less reliably than the marketing suggests. A 2026 systematic review searched the literature to June 2026, included 12 randomised controlled trials of magnesium as a stand-alone intervention, and assessed them with the Cochrane Risk of Bias 2 tool and GRADE.
Results were inconsistent across every outcome type — questionnaires, EEG, research-grade actigraphy, consumer wearables and physiological markers — and the certainty of evidence was rated low to very low. The reviewers concluded that current evidence does not support oral magnesium as a routine treatment for insomnia.
We cover the supplement landscape in our magnesium for sleep guide, and the behaviours with far stronger evidence in how to sleep better after 40.
What about restless legs?
Restless legs syndrome is a distinct neurological condition, not the same thing as a night cramp, and the cramp evidence above does not transfer to it. The nutrient with the strongest link to RLS severity is iron, not magnesium — iron stores correlate with symptom severity even in people whose ferritin reads as normal (Tanoğlu & Ersoy, Sleep Med, 2026).
If you have persistent restless legs, iron status is the thing worth asking a doctor to check. We found no systematic review supporting magnesium as a treatment for it, and say so rather than filling the gap.
Who should be careful, and what interacts with it?
- Anyone with reduced kidney function. This is the one genuinely serious scenario. The kidneys clear excess magnesium; when they cannot, blood magnesium can climb to dangerous levels. Magnesium supplements in chronic kidney disease belong under medical supervision.
- Certain antibiotics. Magnesium binds tetracycline and quinolone antibiotics in the gut and reduces their absorption. The usual pharmacy advice is to separate the doses by several hours — ask your pharmacist for the specific gap.
- Bisphosphonates (osteoporosis medicines) are similarly affected by mineral binding and are normally taken well apart from supplements.
- Proton pump inhibitors run the other way. Long-term PPI use is associated with low magnesium, documented in published case reports — so the issue there is deficiency, not excess.
- Older adults generally, because kidney function declines with age. See magnesium benefits after 40.
What this article does not claim
- That magnesium glycinate is useless. Correcting a genuine deficiency matters. What the evidence does not support is routine use for insomnia or cramps.
- That exceeding 350 mg/day is safe. One group of researchers argues the limit is too conservative. That is a published argument, with a disclosed conflict of interest, not a change to official guidance.
- A dose for you. No dosing recommendation appears here deliberately. That depends on your diet, kidney function and medications.
- That these are all possible effects. This covers what is consistently documented. Individual reactions vary, and anything persistent or severe warrants a doctor, not an article.
Many people try glycinate for night-time cramps rather than sleep. Our review of magnesium for leg cramps looks at what the Cochrane review and newer trials actually found, and what helps instead.
Still choosing a form? Our comparison of magnesium glycinate vs citrate looks at absorption, sleep, constipation and which one suits which goal.
References
- Costello R, Rosanoff A, Nielsen F, West C. Perspective: call for re-evaluation of the tolerable upper intake level for magnesium supplementation in adults. Adv Nutr. 2023;14(5):973-982. PubMed
- Garrison SR, Korownyk CS, Kolber MR, et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. 2020;9(9):CD009402. PubMed
- Lopresti AL, Smith SJ, Drummond PD. Magnesium supplementation for sleep in adults: a systematic review of randomized controlled trials. J Diet Suppl. 2026;23(5):553-581. PubMed
- Pajuelo D, Meissner JM, Negra T, et al. Comparative clinical study on magnesium absorption and side effects after oral intake of microencapsulated magnesium (MAGSHAPE microcapsules) versus other magnesium sources. Nutrients. 2024;16(24):4367. PubMed
- Schuette SA, Lashner BA, Janghorbani M. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr. 1994;18(5):430-435. PubMed
- Tanoğlu C, Ersoy A. Is “normal” ferritin truly enough? Strong correlation between iron stores and RLS severity in patients with normal ferritin levels. Sleep Med. 2026 Sep. PubMed
This article is for informational purposes only and is not medical advice. See our Medical Disclaimer before changing your exercise, diet, or supplement routine.
See every method in action
New research-backed workouts on YouTube every week — no gym required.
Frequently asked questions
What are the side effects of magnesium glycinate?
The main documented side effect is gastrointestinal: loose stools or diarrhea, sometimes with nausea or abdominal cramping. Diarrhea is the specific effect that set the 350 mg per day upper limit for supplemental magnesium in adults (Costello et al., Adv Nutr, 2023). Serious harm is rare and concentrated in people with impaired kidney function, who cannot clear excess magnesium.
Is magnesium glycinate gentler on the stomach than other forms?
Probably, though the evidence is thin. Poorly absorbed forms such as magnesium oxide leave more magnesium in the gut, where it draws in water and loosens stools, and glycinate is often assumed to leave less behind because it is better absorbed. Human data for that are limited: a 12-person 1994 trial found glycinate absorbed about as well as oxide overall, though it was better tolerated. Glycinate can still cause diarrhea at high enough doses.
How much magnesium glycinate is too much?
The US tolerable upper intake level is 350 mg per day of magnesium from supplements alone, set in 1997 with diarrhea as the limiting factor. That is a tolerability threshold rather than a toxicity threshold, and some researchers argue it is too conservative, since several studies using 128 to 1,200 mg per day found no significant excess diarrhea. The 350 mg figure remains official guidance. Dosing decisions should involve a doctor or pharmacist.
Does magnesium glycinate help with muscle cramps?
For ordinary night-time leg cramps in older adults, the evidence says no. A Cochrane review of 11 trials in 735 people found no statistically significant benefit over placebo, including high-certainty evidence that the proportion of people improving by at least 25% was no different from placebo (RR 1.04, 95% CI 0.84 to 1.29). Trials in pregnancy looked more favourable but were all judged at high risk of bias.
Who should avoid magnesium supplements?
Anyone with reduced kidney function should not take magnesium supplements without medical supervision, because impaired clearance can let blood magnesium rise to dangerous levels. Magnesium also reduces absorption of tetracycline and quinolone antibiotics and of bisphosphonates, so doses need separating. Anyone on prescription medication should check with a pharmacist first.
